Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens

Neuroscience

Volumn 135, Issue 1, 2005, Pages 213-225

  Hirose, N ^a   Murakawa, K ^a   Takada, K ^a   Oi, Y ^a   Suzuki, T ^b   Nagase, H ^c   Cools, A R ^d   Koshikawa, N ^a  

^a NIHON UNIVERSITY   (Japan)

^b HOSHI UNIVERSITY   (Japan)

^c KITASATO UNIVERSITY   (Japan)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dopamine release; Nucleus accumbens; Opioid receptors; Rats; Receptor interaction

Indexed keywords

7 BENZYLIDENENALTREXONE; DELTA 1 OPIATE RECEPTOR; DELTA 2 OPIATE RECEPTOR; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; DOPAMINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; NALTRIBEN; OPIATE ANTAGONIST; SODIUM CHANNEL BLOCKING AGENT; TETRODOTOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN PERFUSION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOPAMINE RELEASE; EXTRACELLULAR FLUID; HYPOTHESIS; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; STIMULATION; TIME; WAKEFULNESS;

ANALGESICS, OPIOID; ANESTHETICS, LOCAL; ANIMALS; BENZYLIDENE COMPOUNDS; DOPAMINE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALIN, LEUCINE; EXTRACELLULAR SPACE; MALE; MICRODIALYSIS; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; SOMATOSTATIN; TETRODOTOXIN;

EID: 24044535494     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2005.03.065     Document Type: Article

References (47)

1. A. Alt, M.J. Clark, J.H. Woods, J.R. Traynor Mu and delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells Br J Pharmacol 135 2002 217 225
2. H. Benveniste, A.J. Hansen, N.S. Ottosen Determination of brain interstitial concentrations by microdialysis J Neurochem 52 1989 1741 1750
3. C.L.E. Broekkamp, A.G. Phillips, A.R. Cools Stimulant effects of enkephalin microinjection into the dopaminergic A10 area Nature 278 1979 560 562
4. C.M. Cahill, T.D. White, J. Sawynok Synergy between μ/δ-opioid receptors mediates adenosine release from spinal cord synaptosomes Eur J Pharmacol 298 1996 45 49
5. W.G. Clark, D.C. Brater, A.R. Johnson Pharmacokinetic principles in the use of drugs W.G. Clark D.C. Brater A.R. Johnson Goth's medical pharmacology 12th edition 1988 The C. V. Mosby Company St Louis 13 27
6. 2 opioid receptor stimulation in neonatal and adult rats Resp Physiol 127 2001 157 172
7. D.P. Devine, P. Leone, D. Pocock, R.A. Wise Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release in vivo microdialysis studies J Pharmacol Exp Ther 266 1993 1236 1246
8. G. Di Chiara, A. Imperato Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc Natl Acad Sci U S A 85 1988 5274 5278
9. G. Di Chiara, A. Imperato Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats J Pharmacol Exp Ther 244 1988 1067 1080
10. V. Erspamer, P. Melchiorri, G. Falconieri-Erspamer, L. Negri, R. Corsi, C. Severini, D. Barra, M. Simmaco, G. Kreil Deltorphins a family of naturally occurring peptides with high affinity and selectivity for δ opioid binding sites Proc Natl Acad Sci U S A 86 1989 5188 5192
11. A. Goldstein, A. Naidu Multiple opioid receptors ligand selectivity profiles and binding site signatures Mol Pharmacol 36 1989 265 272
12. B.K. Handa, A.C. Land, J.A. Lord, B.A. Morgan, M.J. Rance, C.F. Smith Analogues of beta-LPH61-64 possessing selective agonist activity at μ-opiate receptors Eur J Pharmacol 70 1981 531 540
13. L.P. Hooke, L. He, N.M. Lee [Des-Tyr1]dynorphin A-(2-17) has naloxone-insensitive antinociceptive effect in the writhing assay J Pharmacol Exp Ther 273 1995 802 807
14. V.J. Hruby, C.A. Gehrig Recent developments in the design of receptor specific opioid peptides Med Res Rev 9 1989 343 401
15. K.W. Kim, S.J. Kim, B.S. Shin, H.Y. Choi Ligand binding profiles of δ-opioid receptor in human cerebral cortex membranes Evidence of δ-opioid receptor heterogeneity Life Sci 68 2001 1649 1656
16. U. Kischka, S.A. Farber, D. Marshall, R.J. Wurtman Carbachol and naloxone synergistically elevate dopamine release in rat striatum an in vivo microdialysis study Brain Res 613 1993 288 290
17. J.E. Koch, R.J. Bodnar Involvement of mu1 and mu2 opioid receptor subtypes in tail-pinch feeding in rats Physiol Behav 53 1993 603 605
18. H.W. Kosterlitz The Wellcome Foundation lecture, 1982. Opioid peptides and their receptors Proc R Soc Lond 225 1985 27 40
19. T.H. Kramer, J.E. Shook, W. Kazmierski, E.A. Ayres, W.S. Wire, V.J. Hruby, T.F. Burks Novel peptidic mu opioid antagonists Pharmacologic characterization in vitro and in vivo J Pharmacol Exp Ther 249 1989 544 551
20. G. Kreil, D. Barra, M. Simmaco, V. Erspamer, G.F. Erspamer, L. Negri, C. Severini, R. Corsi, P. Melchiorri Deltorphin, a novel amphibian skin peptide with high selectivity and affinity for delta opioid receptors Eur J Pharmacol 162 1989 123 128
21. L.G. Latimer, P. Duffy, P.W. Kalivas Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area J Pharmacol Exp Ther 241 1987 328 337
22. P. Leone, D. Pocock, R.A. Wise Morphine-dopamine interaction ventral tegmental morphine increases nucleus accumbens dopamine release Pharmacol Biochem Behav 39 1991 469 472
23. N. Lindefors, G. Amberg, U. Ungerstedt Intracerebral microdialysis: I. Experimental studies of diffusion kinetics J Pharmacol Methods 22 1989 141 156
24. 1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens J Neurosci 11 1991 1565 1576
25. A. Morinville, C.M. Cahill, M.J. Esdaile, H. Aibak, B. Collier, B.L. Kieffer, A. Beaudet Regulation of δ-opioid receptor trafficking via μ-opioid receptor stimulation evidence from μ-opioid receptor knock-out mice J Neurosci 23 2003 4888 4898
26. H.L. Mosberg, R. Hurst, V.J. Hruby, H.I. Yamamura, J.J. Galligan, T.F. Burks Bis-penicillamine enkephalins possess highly improved specificity towards opioid receptors Proc Natl Acad Sci U S A 80 1983 5871 5874
27. T. Murai, N. Koshikawa, T. Kanayama, K. Takada, K. Tomiyama, M. Kobayashi Opposite effects of midazolam and β-carboline-3-carboxylate ethyl ester on the release of dopamine from rat nucleus accumbens measured by in vivo microdialysis Eur J Pharmacol 261 1994 65 71
28. K. Murakawa, N. Hirose, K. Takada, T. Suzuki, H. Nagase, A.R. Cools, N. Koshikawa Deltorphin II enhances extracellular levels of dopamine in the nucleus accumbens via opioid receptor-independent mechanisms Eur J Pharmacol 491 2004 31 36
29. S.J. O'Neill, M.A. Collins, H.O. Pettit, R.W. McNutt, K.-J. Chang Antagonistic modulation between the delta opioid agonist BW373U86 and the mu opioid agonist fentanyl in mice J Pharmacol Exp Ther 282 1997 271 277
30. G.W. Pasternak Insights into mu opioid pharmacology the role of mu opioid receptor subtypes Life Sci 68 2001 2213 2219
31. G. Paxinos, C. Watson The rat brain in stereotaxic coordinates 4th edition 1998 Academic New York
32. J.T. Pelton, W. Kazmierski, K. Gulya, H.I. Yamamura, V.J. Hruby Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for μ opioid receptors J Med Chem 29 1986 2370 2375
33. R.J.W. Pentney, A. Gratton Effects of local delta and mu opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat an in vivo electrochemical study Neuroscience 45 1991 95 102
34. F.E. Pontieri, G. Tanda, G. Di Chiara Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens Proc Natl Acad Sci U S A 92 1995 12304 12308
35. P.S. Portoghese An approach to the design of receptor-type-selective non-peptide antagonists of peptidergic receptors δ opioid antagonists J Med Chem 346 1991 1757 1762
36. P. Riba, Y. Ben, A.P. Smith, S. Furst, N.M. Lee Morphine tolerance in spinal cord is due to interaction between μ- and δ-receptors J Pharmacol Exp Ther 300 2002 265 272
37. B.L. Schmidt, C.H. Tambeli, J.D. Levine, R.W. Gear μ/δ Cooperativity and opposing κ-opioid effects in nucleus accumbens-mediated antinociception in the rat Eur J Neurosci 15 2002 861 868
38. R. Spanagel, A. Herz, T.S. Shippenberg The effects of opioid peptide on dopamine release in the nucleus accumbens an in vivo microdialysis study J Neurochem 55 1990 1734 1740
39. R. Spanagel, A. Herz, T.S. Shippenberg Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway Proc Natl Acad Sci U S A 89 1992 2046 2050
40. P. Stanzione, A. Stefani, P. Calabresi, N.B. Mercuri, G. Bernardi Met- and leu-enkephalins inhibit rat cortical neurons intracellularly recorded in vivo while morphine excites them evidence for naloxone-sensitive and naloxone-insensitive effects Exp Brain Res 77 1989 302 308
41. C.O. Stiller, J. Bergquist, O. Beck, R. Ekman, E. Brodin Local administration of morphine decreases the extracellular level of GABA in the periaqueductal gray matter of freely moving rats Neurosci Lett 209 1996 165 168
42. K. Takada, T. Murai, T. Kanayama, N. Koshikawa Effects of midazolam and flunitrazepam on the release of dopamine from rat striatum measured by in vivo microdialysis Br J Anaesth 70 1993 181 185
43. K. Tomiyama, M. Noguchi, N. Koshikawa, M. Kobayashi YM-09151-2 but not l-sulpiride induces transient dopamine release in rat striatum via a tetrodotoxin-insensitive mechanism J Neurochem 60 1993 1690 1695
44. K. Tomiyama, N. Koshikawa, K. Funada, K. Oka, M. Kobayashi In vivo microdialysis evidence for transient dopamine release by benzazepines in rat striatum J Neurochem 65 1995 2790 2795
45. J.A. Woods, N.A. Shahabi, B.M. Sharp Characterization of a naloxone-insensitive β-endorphin receptor on murine peritoneal macrophages Life Sci 60 1997 573 586
46. Y. Yoshida, S. Koide, N. Hirose, K. Takada, K. Tomiyama, N. Koshikawa, A.R. Cools Fentanyl increases dopamine release in rat nucleus accumbens involvement of mesolimbic mu- and delta-2-opioid receptors Neuroscience 92 1999 1357 1365
47. G.A. Young Dissociation of naloxone-sensitive and naloxone-insensitive effects of U-50,488H Pharmacol Biochem Behav 33 1989 215 217